Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Biogen to Discontinue Development of Stroke Drug After Early-Stage Trial Failure
Biogen to Discontinue Development of Stroke Drug After Early-Stage Trial Failure
Biogen to Discontinue Development of Stroke Drug After Early-Stage Trial Failure
Submitted by
admin
on February 8, 2018 - 10:11am
Source:
Xtalks
News Tags:
Biogen
stroke
clinical trials
natalizumab
Headline:
Biogen to Discontinue Development of Stroke Drug After Early-Stage Trial Failure
Do Not Allow Advertisers to Use My Personal information